Hyper-IgM Immunodeficiency Syndrome, Type 1 [clinicaltrials_resource:62fae4444936f7ed559be71d059aa7e8]
Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome [clinicaltrials:NCT00001145]Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders [clinicaltrials:NCT00004341]Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States [clinicaltrials:NCT00266513]clinicaltrials:NCT01289847Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies [clinicaltrials:NCT01652092]Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases [clinicaltrials:NCT01963143]
condition browse [clinicaltrials_vocabulary:condition-browse]
Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome [clinicaltrials:NCT00001145]Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders [clinicaltrials:NCT00004341]Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States [clinicaltrials:NCT00266513]clinicaltrials:NCT01289847Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies [clinicaltrials:NCT01652092]Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases [clinicaltrials:NCT01963143]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Hyper-IgM Immunodeficiency Syndrome, Type 1 [clinicaltrials_resource:62fae4444936f7ed559be71d059aa7e8]
Bio2RDF identifier
62fae4444936f7ed559be71d059aa7e8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:62fae4444936f7ed559be71d059aa7e8
identifier
clinicaltrials_resource:62fae4444936f7ed559be71d059aa7e8
title
Hyper-IgM Immunodeficiency Syndrome, Type 1
@en
type
label
Hyper-IgM Immunodeficiency Syn ...... ae4444936f7ed559be71d059aa7e8]
@en
Hyper-IgM Immunodeficiency Syndrome, Type 1